PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,650,836 | -20.7% | 40,591 | -5.6% | 0.00% | -25.0% |
| Q1 2023 | $2,081,903 | +44.2% | 42,979 | +13.6% | 0.00% | +33.3% |
| Q4 2022 | $1,443,971 | -26.2% | 37,830 | -2.9% | 0.00% | -25.0% |
| Q3 2022 | $1,956,000 | +17.8% | 38,961 | -6.0% | 0.00% | 0.0% |
| Q2 2022 | $1,661,000 | -1.0% | 41,468 | -7.7% | 0.00% | +33.3% |
| Q1 2022 | $1,677,000 | -4.3% | 44,938 | +2.1% | 0.00% | 0.0% |
| Q4 2021 | $1,753,000 | +6.6% | 44,007 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $1,645,000 | -12.5% | 44,216 | -0.6% | 0.00% | -25.0% |
| Q2 2021 | $1,881,000 | +10.3% | 44,500 | +23.6% | 0.00% | 0.0% |
| Q1 2021 | $1,705,000 | -51.8% | 36,000 | -37.9% | 0.00% | -55.6% |
| Q4 2020 | $3,536,000 | +31.8% | 57,937 | +1.0% | 0.01% | +12.5% |
| Q3 2020 | $2,682,000 | -39.2% | 57,366 | -34.0% | 0.01% | -42.9% |
| Q2 2020 | $4,412,000 | +51.9% | 86,949 | +33.6% | 0.01% | +27.3% |
| Q1 2020 | $2,904,000 | +194.8% | 65,087 | +217.5% | 0.01% | +266.7% |
| Q4 2019 | $985,000 | +603.6% | 20,500 | +451.8% | 0.00% | – |
| Q1 2019 | $140,000 | -52.4% | 3,715 | -40.6% | 0.00% | -100.0% |
| Q4 2018 | $294,000 | 0.0% | 6,255 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $294,000 | +764.7% | 6,255 | +525.5% | 0.00% | – |
| Q2 2018 | $34,000 | +25.9% | 1,000 | 0.0% | 0.00% | – |
| Q1 2018 | $27,000 | +58.8% | 1,000 | 0.0% | 0.00% | – |
| Q4 2017 | $17,000 | -22.7% | 1,000 | -10.3% | 0.00% | – |
| Q3 2017 | $22,000 | +22.2% | 1,115 | +11.5% | 0.00% | – |
| Q2 2017 | $18,000 | +80.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $10,000 | -9.1% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $11,000 | -97.3% | 1,000 | -96.5% | 0.00% | -100.0% |
| Q3 2016 | $404,000 | +98.0% | 28,869 | -0.7% | 0.00% | +100.0% |
| Q2 2016 | $204,000 | +83.8% | 29,081 | +67.7% | 0.00% | 0.0% |
| Q1 2016 | $111,000 | -91.6% | 17,340 | -57.7% | 0.00% | -87.5% |
| Q4 2015 | $1,329,000 | -14.9% | 41,009 | -29.9% | 0.01% | -42.9% |
| Q3 2015 | $1,561,000 | -35.6% | 58,474 | +16.1% | 0.01% | -36.4% |
| Q2 2015 | $2,424,000 | +58.7% | 50,368 | +100.5% | 0.02% | +69.2% |
| Q1 2015 | $1,527,000 | – | 25,116 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
| RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
| GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
| Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
| ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
| CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
| Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
| Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |